Skip to main content
Erschienen in: Journal of Neural Transmission 5/2012

01.05.2012 | Movement Disorders - Original Article

Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson’s disease-dementia: which matters most?

verfasst von: Francesca Di Biasio, Nicola Vanacore, Alfonso Fasano, Nicola Modugno, Barbara Gandolfi, Francesco Lena, Giovanni Grillea, Sara Pietracupa, Giovanni Caranci, Stefano Ruggieri

Erschienen in: Journal of Neural Transmission | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder affecting not only the motor system but also the cognitive and behavioral domains. Although there are many studies addressing the issue of cognition, a universally recognized method to diagnose patients with dementia is still lacking. The aim of this study was to determine which neuropsychological test is the most reliable in the diagnosis of dementia in PD and to establish if mini mental state examination (MMSE) is enough to detect this condition. We studied 200 consecutive PD patients through an extensive neuropsychological battery, clinical evaluation and brain magnetic resonance imaging over a period of 4 years. A logistic regression model was used to evaluate the interplay between possible risk factors and the accuracy of different neuropsychological tests. PD patients with dementia performed significantly worse in all the tests as compared to patients with PD alone: phonological verbal fluency, attentional matrices, Rey auditory verbal learning test and digit span were the most useful tools. Age and disease duration were correlated with cognitive impairment. No relevant differences were detected in phenotype, affected body side at onset, levodopa equivalent daily dose or neuroimaging findings (except for the occurrence of atrophy). Despite reasonable accuracy of MMSE (90%), its positive predictive value is only 74%. Using at least 3 neuropsychological tests, among those more significant detected with logistic regression analysis, the positive predictive value rises to 91%. In conclusion, the use of an extensive neuropsychological battery is still recommended in the diagnosis of dementia in PD.
Literatur
Zurück zum Zitat Aarsland D, Andresen Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, Kragh-Sørensen P (2004) The rate of cognitive decline in Parkinson disease. Arch Neurol 61:1906–1911PubMedCrossRef Aarsland D, Andresen Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, Kragh-Sørensen P (2004) The rate of cognitive decline in Parkinson disease. Arch Neurol 61:1906–1911PubMedCrossRef
Zurück zum Zitat Aarsland D, Zaccai J, Brayne C (2005) A Systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 20:1255–1263PubMedCrossRef Aarsland D, Zaccai J, Brayne C (2005) A Systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 20:1255–1263PubMedCrossRef
Zurück zum Zitat American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington Text revision American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington Text revision
Zurück zum Zitat Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:254–259PubMedCrossRef Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:254–259PubMedCrossRef
Zurück zum Zitat Borkowski JG, Benton AL, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5:135–140CrossRef Borkowski JG, Benton AL, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5:135–140CrossRef
Zurück zum Zitat Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef
Zurück zum Zitat Caltagirone C, Gainotti G, Carlesimo GA, Parnetti L (1995) Batteria per la valutazione del deterioramento mentale (parte I): descrizione di uno strumento per la diagnosi neuropsicologica. Arch Psicol Neurol Psichiatr 55:461–470 Caltagirone C, Gainotti G, Carlesimo GA, Parnetti L (1995) Batteria per la valutazione del deterioramento mentale (parte I): descrizione di uno strumento per la diagnosi neuropsicologica. Arch Psicol Neurol Psichiatr 55:461–470
Zurück zum Zitat Caparros-Lefebvre D, Pecheux N, Petit V, Duhamel A, Petit M (1995) Which factors predict cognitive decline in Parkinson’s disease? J Neurol Neurosurg Psychiatry 58:51–55PubMedCrossRef Caparros-Lefebvre D, Pecheux N, Petit V, Duhamel A, Petit M (1995) Which factors predict cognitive decline in Parkinson’s disease? J Neurol Neurosurg Psychiatry 58:51–55PubMedCrossRef
Zurück zum Zitat Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5:275–283PubMedCrossRef Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5:275–283PubMedCrossRef
Zurück zum Zitat Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability. Brain 114:2095–2122PubMedCrossRef Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability. Brain 114:2095–2122PubMedCrossRef
Zurück zum Zitat Cormack F, Aarsland D, Ballard C, Tovée MJ (2004) Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer’s disease, Parkinson’s disease and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 19:371–377PubMedCrossRef Cormack F, Aarsland D, Ballard C, Tovée MJ (2004) Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer’s disease, Parkinson’s disease and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 19:371–377PubMedCrossRef
Zurück zum Zitat Cummings JL (1988) Intellectual impairment in Parkinson’s disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1:24–36PubMedCrossRef Cummings JL (1988) Intellectual impairment in Parkinson’s disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1:24–36PubMedCrossRef
Zurück zum Zitat Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, Caviness JN, Adler JH (2011) The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord 31:126–131PubMedCrossRef Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, Caviness JN, Adler JH (2011) The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord 31:126–131PubMedCrossRef
Zurück zum Zitat Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y (1990) Age-induced cognitive disturbances in Parkinson’s disease. Neurology 40:38–41PubMed Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y (1990) Age-induced cognitive disturbances in Parkinson’s disease. Neurology 40:38–41PubMed
Zurück zum Zitat Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324PubMedCrossRef Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324PubMedCrossRef
Zurück zum Zitat Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Peré JJ, Duhamel A, EXECUTIVE study group (2010) Parkinson’s disease dementia can be easily detected in routine clinical practice. Mov Disord 25:2769–2776PubMedCrossRef Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Peré JJ, Duhamel A, EXECUTIVE study group (2010) Parkinson’s disease dementia can be easily detected in routine clinical practice. Mov Disord 25:2769–2776PubMedCrossRef
Zurück zum Zitat Emre M (2003b) What causes mental dysfunction in Parkinson’s disease? Mov Disord 18(Suppl 6):S63–S71PubMedCrossRef Emre M (2003b) What causes mental dysfunction in Parkinson’s disease? Mov Disord 18(Suppl 6):S63–S71PubMedCrossRef
Zurück zum Zitat Emre M (2004) Dementia in Parkinson’s disease: cause and treatment. Curr Opin Neurol 17:399–404PubMedCrossRef Emre M (2004) Dementia in Parkinson’s disease: cause and treatment. Curr Opin Neurol 17:399–404PubMedCrossRef
Zurück zum Zitat Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707PubMedCrossRef Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707PubMedCrossRef
Zurück zum Zitat Finali G, Piccirilli M, Rizzuto S (2005) Neuropsychological characteristics of parkinsonian patients with lateralized motor impairment. J Neural Transm Park Dis Dement Sect 9:165–176 Finali G, Piccirilli M, Rizzuto S (2005) Neuropsychological characteristics of parkinsonian patients with lateralized motor impairment. J Neural Transm Park Dis Dement Sect 9:165–176
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
Zurück zum Zitat Gabrieli JDE, Singh J, Stebbins GT, Goetz CG (1996) Reduced working memory span in Parkinson’s disease: evidence for the role of frontostriatal system in working and strategic memory. Neuropsychology 10:322–332CrossRef Gabrieli JDE, Singh J, Stebbins GT, Goetz CG (1996) Reduced working memory span in Parkinson’s disease: evidence for the role of frontostriatal system in working and strategic memory. Neuropsychology 10:322–332CrossRef
Zurück zum Zitat Galvin Je, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67:1605–1611PubMedCrossRef Galvin Je, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67:1605–1611PubMedCrossRef
Zurück zum Zitat Hagell P, Brundin L (2009) Towards an understanding of fatigue in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80:489–492PubMedCrossRef Hagell P, Brundin L (2009) Towards an understanding of fatigue in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80:489–492PubMedCrossRef
Zurück zum Zitat Hely MA, Morris JG, Trafficante R (2005) Sydney study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–199PubMedCrossRef Hely MA, Morris JG, Trafficante R (2005) Sydney study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–199PubMedCrossRef
Zurück zum Zitat Hietanen M, Teräväinen H (1988) The effect of age of disease onset on neuropsychological performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:244–249PubMedCrossRef Hietanen M, Teräväinen H (1988) The effect of age of disease onset on neuropsychological performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:244–249PubMedCrossRef
Zurück zum Zitat Hobsen P, Meara J (1999) The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson’s disease by use of the CAMOG neuropsychological test. Age Ageing 28:39–43CrossRef Hobsen P, Meara J (1999) The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson’s disease by use of the CAMOG neuropsychological test. Age Ageing 28:39–43CrossRef
Zurück zum Zitat Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in United Kingdom. Mov Disord 19:1043–1049PubMedCrossRef Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in United Kingdom. Mov Disord 19:1043–1049PubMedCrossRef
Zurück zum Zitat Hughes AJ, Daniel SEE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50:140–148PubMedCrossRef Hughes AJ, Daniel SEE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50:140–148PubMedCrossRef
Zurück zum Zitat Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ (2009) MRI and cognitive impairment in Parkinson’s disease. Mov Disord 24:S748–S753PubMedCrossRef Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ (2009) MRI and cognitive impairment in Parkinson’s disease. Mov Disord 24:S748–S753PubMedCrossRef
Zurück zum Zitat Katzen HL, Levin BE, Llabre ML (1998) Age of disease onset influences cognition in Parkinson’s disease. J Int Neuropsychol Soc 4:285–290PubMed Katzen HL, Levin BE, Llabre ML (1998) Age of disease onset influences cognition in Parkinson’s disease. J Int Neuropsychol Soc 4:285–290PubMed
Zurück zum Zitat Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121:451–457PubMedCrossRef Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121:451–457PubMedCrossRef
Zurück zum Zitat Kukull WA, Larson EB, Teri L, Bowen J, McCormick W, Pfanschmidt ML (1994) The Mini-Mental state examination score and the clinical diagnosis of dementia. J Clin Epidemiol 47:1061–1067PubMedCrossRef Kukull WA, Larson EB, Teri L, Bowen J, McCormick W, Pfanschmidt ML (1994) The Mini-Mental state examination score and the clinical diagnosis of dementia. J Clin Epidemiol 47:1061–1067PubMedCrossRef
Zurück zum Zitat Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD (2006) Long term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson’s disease. Stereotact Funct Neurosurg 84:221–227PubMedCrossRef Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD (2006) Long term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson’s disease. Stereotact Funct Neurosurg 84:221–227PubMedCrossRef
Zurück zum Zitat Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 18:467–486PubMedCrossRef Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 18:467–486PubMedCrossRef
Zurück zum Zitat Manolio TA, Kronmal RA, Burke GL, Poirier V, O’Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN (1994) Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 25:318–327PubMedCrossRef Manolio TA, Kronmal RA, Burke GL, Poirier V, O’Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN (1994) Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 25:318–327PubMedCrossRef
Zurück zum Zitat Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson’s disease: clinical analysis of 100 patients. Neurology 23:783–790PubMed Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson’s disease: clinical analysis of 100 patients. Neurology 23:783–790PubMed
Zurück zum Zitat Marttila RJ, Rinne UK (1976) Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand 53:81–102PubMedCrossRef Marttila RJ, Rinne UK (1976) Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand 53:81–102PubMedCrossRef
Zurück zum Zitat Novelli G, Papagno C, Capitani E, Laiacona M, Valler G, Cappa SF (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr 47:477–506 Novelli G, Papagno C, Capitani E, Laiacona M, Valler G, Cappa SF (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr 47:477–506
Zurück zum Zitat Orsini A, Grossi D, Capitani E, Laiacona E, Papagno C, Vallar G (1987) Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 8:539–548PubMedCrossRef Orsini A, Grossi D, Capitani E, Laiacona E, Papagno C, Vallar G (1987) Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 8:539–548PubMedCrossRef
Zurück zum Zitat Spinnler H, Tognoni G (1987) Standardizzazione e Taratura italiana di Test neuropsicologici. Ital J Neurol Sci 6:21–120 Spinnler H, Tognoni G (1987) Standardizzazione e Taratura italiana di Test neuropsicologici. Ital J Neurol Sci 6:21–120
Zurück zum Zitat Stern Y, Marder K, Tang MX, Mayeux R (1993) Antecedent clinical features associated with dementia in Parkinson’s disease. Neurology 43:1690–1692PubMed Stern Y, Marder K, Tang MX, Mayeux R (1993) Antecedent clinical features associated with dementia in Parkinson’s disease. Neurology 43:1690–1692PubMed
Zurück zum Zitat Williams-Gray CH, Foltynie T, Brayne GEG, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 130:1787–1798PubMedCrossRef Williams-Gray CH, Foltynie T, Brayne GEG, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 130:1787–1798PubMedCrossRef
Metadaten
Titel
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson’s disease-dementia: which matters most?
verfasst von
Francesca Di Biasio
Nicola Vanacore
Alfonso Fasano
Nicola Modugno
Barbara Gandolfi
Francesco Lena
Giovanni Grillea
Sara Pietracupa
Giovanni Caranci
Stefano Ruggieri
Publikationsdatum
01.05.2012
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 5/2012
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-011-0733-3

Weitere Artikel der Ausgabe 5/2012

Journal of Neural Transmission 5/2012 Zur Ausgabe

Biological Psychiatry - CONy Pro/Con debate

The first phase of a migraine attack resides in the cortex

Biological Psychiatry - CONy Pro/Con debate

Why all migraine patients should be treated with magnesium

Biological Psychiatry - CONy Pro/Con debate

Where does a migraine attack originate? In the brainstem

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.